Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

Details for Australian Patent Application No. 2005273612 (hide)

Owner Pfizer Inc.

Inventors Phillips, Christopher; Millan, David Simon; Lewthwaite, Russell Andrew; Mathias, John Paul

Agent Allens Arthur Robinson

Pub. Number AU-B-2005273612

PCT Pub. Number WO2006/018718

Priority 60/691,559 17.06.05 US; 0418015.4 12.08.04 GB

Filing date 9 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 14 October 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/4745 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 321/28 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/018718 Priority application(s): WO2006/018718

14 October 2010 Application Accepted

  Published as AU-B-2005273612

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005273619-Inhibitors of hepatitis C virus RNAdependent RNA polymerase, and compositions and treatments using the same

2005273611-Caching directory server data for controlling the disposition of multimedia data on a network